Ignite Creation Date:
2025-12-24 @ 7:25 PM
Ignite Modification Date:
2025-12-25 @ 5:06 PM
Study NCT ID:
NCT01202903
Status:
COMPLETED
Last Update Posted:
2015-03-23
First Post:
2010-09-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-09
Start Date Type:
None
Primary Completion Date:
2013-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-10
Completion Date Type:
ACTUAL
First Submit Date:
2010-09-14
First Submit QC Date:
None
Study First Post Date:
2010-09-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-10-24
Results First Submit QC Date:
None
Results First Post Date:
2015-03-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-16
Last Update Post Date:
2015-03-23
Last Update Post Date Type:
ESTIMATED